ClinicalTrialsFinder
RecruitingNCT06291597

Vaping Adverse Lung and Heart Events Cohort

VapALERT: A Prospective, Exploratory and Adaptive Cohort Study to Identify Symptomatic and Asymptomatic Pulmonary and Cardiovascular Effects of Vaping

Sponsor

Laval University

Enrollment

250 participants

Start Date

Oct 14, 2021

Study Type

OBSERVATIONAL

Conditions

VapingElectronic Cigarette Use

Summary

This prospective study assesses the pulmonary and cardiovascular effets of vaping in adult electronic cigarette users with biannual visits and a 5-year follow-up.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Vaping for people with electronic cigarette use and vaping. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERVaping

Participants use their vaping products at their own discretion and their intake is monitored via questionnaires.

Locations(1)

IUCPQ-UL

Québec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06291597

Related Trials

Social Media Support Groups for Adolescent Vaping Cessation

NCT075407801 location

E-cigarette Social Media Marketing and Its Perceptions by Youth

NCT076947391 location

Varenicline and Accelerated Transcranial Magnetic Stimulation (TMS) for Quitting Nicotine Use (Pilot Study)

NCT071458661 location

Behavioral Intervention for Youth to Promote Vaping Cessation

NCT067652911 location

Developing and Testing Health Warning Labels on the ENDS Device

NCT049071361 location